NO20035333D0 - Ny ligand for nikotiniske acetylkolinreseptorer som er nyttig i terapi - Google Patents

Ny ligand for nikotiniske acetylkolinreseptorer som er nyttig i terapi

Info

Publication number
NO20035333D0
NO20035333D0 NO20035333A NO20035333A NO20035333D0 NO 20035333 D0 NO20035333 D0 NO 20035333D0 NO 20035333 A NO20035333 A NO 20035333A NO 20035333 A NO20035333 A NO 20035333A NO 20035333 D0 NO20035333 D0 NO 20035333D0
Authority
NO
Norway
Prior art keywords
therapy
nicotinic acetylcholine
acetylcholine receptors
new ligand
receptors useful
Prior art date
Application number
NO20035333A
Other languages
English (en)
Inventor
Eifion Phillips
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20035333D0 publication Critical patent/NO20035333D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
NO20035333A 2001-06-01 2003-11-28 Ny ligand for nikotiniske acetylkolinreseptorer som er nyttig i terapi NO20035333D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29520601P 2001-06-01 2001-06-01
PCT/SE2002/001031 WO2002096912A1 (en) 2001-06-01 2002-05-29 Novel ligand for nicotinic acetylcholine receptors useful in therapy

Publications (1)

Publication Number Publication Date
NO20035333D0 true NO20035333D0 (no) 2003-11-28

Family

ID=23136711

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035333A NO20035333D0 (no) 2001-06-01 2003-11-28 Ny ligand for nikotiniske acetylkolinreseptorer som er nyttig i terapi

Country Status (19)

Country Link
EP (1) EP1397366B1 (no)
JP (1) JP2004532877A (no)
KR (1) KR20040003021A (no)
CN (1) CN1294136C (no)
AT (1) ATE353332T1 (no)
BR (1) BR0210075A (no)
CA (1) CA2455341A1 (no)
DE (1) DE60218032T2 (no)
DK (1) DK1397366T3 (no)
ES (1) ES2280538T3 (no)
HK (1) HK1063787A1 (no)
IL (1) IL158735A0 (no)
MX (1) MXPA03010996A (no)
NO (1) NO20035333D0 (no)
NZ (1) NZ529426A (no)
PT (1) PT1397366E (no)
SI (1) SI1397366T1 (no)
WO (1) WO2002096912A1 (no)
ZA (1) ZA200308779B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
JP4511195B2 (ja) * 2002-04-18 2010-07-28 アストラゼネカ・アクチエボラーグ フリル化合物
JP4511196B2 (ja) 2002-04-18 2010-07-28 アストラゼネカ・アクチエボラーグ チエニル化合物
DE60328010D1 (de) * 2002-04-18 2009-07-30 Astrazeneca Ab Heterocyclische verbindungen
JP4855264B2 (ja) 2003-10-21 2012-01-18 アストラゼネカ・アクチエボラーグ スピロフロピリジンアリール誘導体
TW200813067A (en) * 2006-05-17 2008-03-16 Astrazeneca Ab Nicotinic acetylcholine receptor ligands
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
AU2009260905B2 (en) 2008-06-20 2012-08-23 Astrazeneca Ab Dibenzothiazepine derivatives and use thereof
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
PT3029039T (pt) 2010-05-17 2017-11-28 Forum Pharmaceuticals Inc Formulações farmacêuticas que compreendem formas cristalinas de cloridrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida mono-hidratado
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
CA2872005A1 (en) 2012-05-08 2013-11-14 Forum Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function
GB201209587D0 (en) 2012-05-30 2012-07-11 Takeda Pharmaceutical Therapeutic compounds
EP2953940B1 (en) 2013-02-07 2018-08-22 Heptares Therapeutics Limited Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic m4 receptor agonists
CN105324372B (zh) 2013-06-21 2018-03-06 武田药品工业株式会社 作为前动力蛋白受体调节剂的1‑磺酰基哌啶衍生物
GB201314286D0 (en) 2013-08-08 2013-09-25 Takeda Pharmaceutical Therapeutic Compounds
GB201318222D0 (en) 2013-10-15 2013-11-27 Takeda Pharmaceutical Novel compounds
GB201320905D0 (en) 2013-11-27 2014-01-08 Takeda Pharmaceutical Therapeutic compounds
TW201613864A (en) 2014-02-20 2016-04-16 Takeda Pharmaceutical Novel compounds
GB201616839D0 (en) 2016-10-04 2016-11-16 Takeda Pharmaceutical Company Limited Therapeutic compounds
GB201619514D0 (en) 2016-11-18 2017-01-04 Takeda Pharmaceuticals Co Novel compounds
JP2021138648A (ja) 2020-03-04 2021-09-16 武田薬品工業株式会社 経口固形製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0984970B1 (en) * 1997-05-30 2003-11-19 Neurosearch A/S Spiro-quinuclidine derivatives, their preparation and use
AR013184A1 (es) * 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv) * 1999-01-15 1999-01-15 Astra Ab New compounds

Also Published As

Publication number Publication date
ES2280538T3 (es) 2007-09-16
MXPA03010996A (es) 2004-02-27
IL158735A0 (en) 2004-05-12
CA2455341A1 (en) 2002-12-05
DE60218032D1 (de) 2007-03-22
KR20040003021A (ko) 2004-01-07
WO2002096912A1 (en) 2002-12-05
CN1294136C (zh) 2007-01-10
BR0210075A (pt) 2004-08-17
ATE353332T1 (de) 2007-02-15
DE60218032T2 (de) 2007-08-16
ZA200308779B (en) 2005-02-11
JP2004532877A (ja) 2004-10-28
EP1397366B1 (en) 2007-02-07
NZ529426A (en) 2005-07-29
EP1397366A1 (en) 2004-03-17
PT1397366E (pt) 2007-04-30
HK1063787A1 (en) 2005-01-14
CN1512995A (zh) 2004-07-14
DK1397366T3 (da) 2007-05-07
SI1397366T1 (sl) 2007-06-30

Similar Documents

Publication Publication Date Title
NO20035333D0 (no) Ny ligand for nikotiniske acetylkolinreseptorer som er nyttig i terapi
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
CY1113054T1 (el) Παραγωγα διαμινης
NO20052993D0 (no) 4,5-diaryltiazolderivater som CB-1 ligander.
NO20041560L (no) 1,6-nafthyridinderivater som antidiabetiske midler
ATE470662T1 (de) Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
DE60334536D1 (de) Furylverbindungen
DE60112974D1 (en) Carbolinderivate
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
ATE403429T1 (de) Spiropyrazol-verbindungen
ATE477256T1 (de) Thienylverbindungen
MXPA03007142A (es) Derivados de carbolina.
YU39803A (sh) Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
RS52315B (en) DIARYLMETHYL PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE
BRPI0512310A (pt) compostos quìmicos
AU2001266575A1 (en) Chemical compounds
DK1975164T3 (da) Octahydrobenzimidazolon-forbindelser som analgetika
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
BR0109542A (pt) Derivados de imidazopirina alquilados
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
DE60112960D1 (de) Kondensierte pyridoindolderivate
BR0007922A (pt) Compostos calcilìticos
DK1206256T3 (da) Kombinationsbehandling under anvendelse af pentafluorbenzensulfonamid og platinforbindelse
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.